Cell Therapeutics, Inc. (CTIC) announced the results from its Annual Meeting of Shareholders held on October 20, 2009.
At the meeting, shareholders elected Richard Love, Mary Mundinger, and Jack Singer to serve on the Company's Board of Directors until the 2012 Annual Meeting. Shareholders also approved the proposals to increase the number of shares available for issuance under its 2007 Equity Incentive Plan, increase the number of shares available for issuance under its 2007 Employee Purchase Plan and issue shares of common stock in lieu of future milestone payments related to the Company's drug candidate brostallicin.
Further, shareholders ratified the selection of Stonefield Josephson, Inc. as the Company's independent auditors for the year ending December 31, 2009.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.